Advanced Biomed closes $6.56M IPO of 1.64M shares at $4.00; Nasdaq ADVB

Advanced Biomed Inc.

Priced 1,640,000 shares at $4.00/share for gross proceeds of $6.56 million.
Underwriter granted 45-day option to purchase up to 246,000 additional shares.
Representative's warrants to purchase 98,400 shares at $5.00/share.
Proceeds to fund IVD clinical research, chip development, marketing, and working capital.
Shares commenced trading on Nasdaq Capital Market on March 6, 2025 under ticker ADVB.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.